Streetbeat News

Equity Actions

PARA

Paramount Global's stock price has decreased following the sale of approximately 30.4 million shares by Berkshire Hathaway.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 1:40 pm

NMG

SOUN

YETI

YETI shares dropped 15% after reporting Q4 results below estimates and a lower FY24 earnings guidance. BlackRock disclosed a 5.6% passive stake in SoundHound AI, leading to a 97% surge in SOUN shares. Nouveau Monde Graphite announced an offtake agreement with GM for Canadian graphite and a $150M equity investment, causing NMG shares to soar by 137%.

Portfolio Pulse from ryanfaloona@benzinga.com

February 15, 2024 | 1:39 pm

STLA

Stellantis shares are trading higher following the announcement of improved FY23 financial results, an increased dividend, and a new share buyback program.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 1:38 pm

BNZI

The SEC has declared the Form S-1 registration statement of Banzai (BNZI) effective, paving the way for its initial public offering (IPO).

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 1:34 pm

LEXX

Lexaria Bioscience Corp. has announced a registered direct offering of 1,558,443 shares, priced at $2.31 per share, aiming to raise approximately $3.6 million.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 1:21 pm

WINV

WinVest Acquisition Corp. (NASDAQ:WINV) has extended its termination date for completing an initial business combination from February 17, 2024, to March 17, 2024. This extension allows more time for the company to finalize a business combination. Additionally, $55,000 has been added to the trust account for this purpose, funded through a drawdown on a promissory note issued to WinVest SPAC LLC, the company's sponsor.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 1:14 pm

VCNX

Vaccinex, Inc. (NASDAQ:VCNX), a biotech company, announced a 1-for-14 reverse stock split effective February 19, 2024, to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The split-adjusted trading will start on February 20, 2024. The company's stockholders approved this action on February 8, 2024, and the Board of Directors selected the 1-for-14 ratio from a range of options. Vaccinex aims to meet Nasdaq's compliance by March 4, 2024, requiring a closing bid price of at least $1.00 for 10 consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 1:06 pm

VVOS

Vivos Therapeutics, Inc. (VVOS) announced the exercise of a common stock purchase warrant by an institutional investor, resulting in gross proceeds of approximately $4.0 million for Vivos. The transaction involves the purchase of 980,393 shares at a revised price of $4.02 per share. Additionally, Vivos will issue two new unregistered warrants for a total of 1,470,592 shares at $5.05 per share. A.G.P./Alliance Global Partners is the financial advisor for the offering.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 1:04 pm

FIVN

Eight analysts have recently updated their recommendations for Five9 (NASDAQ:FIVN), showing a mix of bullish and somewhat bullish perspectives with no bearish views. The average 12-month price target is now $91.62, up from $84.40, indicating an 8.55% increase. Analysts from firms including Needham, Keybanc, Piper Sandler, Deutsche Bank, Truist Securities, and Wells Fargo have adjusted their ratings and price targets, reflecting positive sentiment towards Five9's market position despite its challenges in revenue growth, net margin, ROE, ROA, and debt management compared to industry averages.

Portfolio Pulse from Benzinga Insights

February 15, 2024 | 1:00 pm

TYL

In the past three months, Tyler Technologies (NYSE:TYL) received varied analyst ratings, with a recent average price target of $486.00, marking a 2.32% increase from the previous target. The company's financial health shows below-average market capitalization, revenue growth, net margin, ROE, and ROA compared to industry peers, but a conservative debt management approach. Analysts' ratings and price targets reflect their views on the company's performance and market conditions.

Portfolio Pulse from Benzinga Insights

February 15, 2024 | 1:00 pm